glp 1 next generation What is the pipeline for future medications for obesity? GLP-1 Genetics: How Genes Affect
Description
In hindlimb-unloading rats, exenatide improves bone mass by promoting osteogenic differentiation of bone marrow stem cells [861]
Eligible subjects were randomised 1:1 to liraglutide 1.8 mg ( N = 26) once-daily subcutaneously or placebo ( N = 26) for 48 weeks
doi: 10.2147/DMSO.S215789
Analyses of the STEP 1-3 trials showing semaglutide improved kidney function in overweight or obese patients
Additionally, switching between medications may interrupt your adherence to the medication
